Pacific NorthWest Regional Center of Excellence (PNWRCE)

西北太平洋区域卓越中心 (PNWRCE)

• 批准号: 8436308
• 负责人: JAY A NELSON
• 金额: $ 723.05万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-20 至 2015-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8436308
• 关键词: Alleles; Antiviral Agents; Apoptosis; Biochemical; Burkholderia pseudomallei; Categories; Defect; Disease; Disease Outcome; Ebola virus; Exhibits; Flavivirus Infections; Francisella; Genetic; Goals; Growth; Immune; Immune response; Immune system; Immunity; Immunotherapy; Individual; Institution; National Institute of Allergy and Infectious Disease; Organism; Pacific Northwest; Pathogenesis; Phase; Predisposition; Proteomics; Signal Transduction; System; Systems Biology; T-Lymphocyte; Vaccines; Virus; Virus Replication; Vulnerable Populations; age related; aged; biodefense; cellular targeting; chemical genetics; functional genomics; mutant; new therapeutic target; novel; novel vaccines; pathogen; programs; response; therapeutic target; virus pathogenesis

The goal of this application is to establish the Pacific Northwest Regional Center of Excellence (PNWRCE) in NIAID Region X. The two inter-related but distinct PNWRCE themes that we have selected reflect not only the scientific strengths at our institutions but also the unmet needs that we perceive are absent in the NIAID biodefense and emerging disease program. The first theme "Identification of Age-Related Defects in the Immune System to Develop Vaccines and Supplemental Therapies" will include two projects. The overall goal of these projects is to develop new vaccines and immune supplemental therapies for immune vulnerable populations such as aged individuals. The first project a P01 will investigate the hypothesis that certain unifying manipulations can be performed to increase T cell immunity in immune vulnerable populations to a broad group of pathogens. The second project will develop a novel and effective vaccine platform for safely immunizing both healthy and vulnerable populations against YFV. The second theme will center on "The use of systems biology, functional genomics and genetics to characterize pathogen-host response for biodefense and emerging disease organisms." This theme will include four projects with the overall goal of using systems approaches to identify new targets and therapeutics for Category A-C agents. The goal of the first project a P01 is to use systems approaches to identify common host susceptibility alleles and signaling circuitry that enhance highly pathogenic pneumonic viruses and Ebola virus replication and pathogenesis and to identify key cellular targets and immune correlates that influence severe disease outcomes. The goal of the second project a P01 is focused on defining innate immune mechanisms, therapeutic targets, and antiviral compounds that limit flavivirus infection and pathogenesis. The third project an R01 will use systems approaches to characterize Francisella mutants that exhibit either altered intracellular growth rates or induce cellular apoptosis. The last project an RO1 will use a combination of genetic, biochemical, and computational approaches to elucidate B. pseudomallei host pathogen response during both the septicemic as well as the intracellular phases of the disease.

本申请的目标是在NIAID x区建立太平洋西北区域卓越中心（PNWRCE）。我们选择的两个相互关联但不同的PNWRCE主题不仅反映了我们机构的科学优势，而且反映了我们认为NIAID生物防御和新发疾病项目中缺乏的未满足的需求。第一个主题是“确定免疫系统中与年龄相关的缺陷，以开发疫苗和补充疗法”，将包括两个项目。这些项目的总体目标是为老年人等免疫脆弱人群开发新的疫苗和免疫补充疗法。第一个项目P01将研究这样一个假设，即可以通过某些统一的操作来提高免疫易感人群对多种病原体的T细胞免疫力。第二个项目将开发一种新的有效疫苗平台，为健康人群和脆弱人群安全接种YFV。第二个主题将集中在“使用系统生物学，功能基因组学和遗传学来表征生物防御和新出现的疾病生物体的病原体-宿主反应”。该主题将包括四个项目，其总体目标是使用系统方法确定A-C类药物的新靶点和治疗方法。第一个项目P01的目标是使用系统方法识别增强高致病性肺炎病毒和埃博拉病毒复制和发病机制的常见宿主易感等位基因和信号通路，并识别影响严重疾病结局的关键细胞靶点和免疫相关物。第二个项目P01的目标是确定先天免疫机制、治疗靶点和限制黄病毒感染和发病机制的抗病毒化合物。R01的第三个项目将使用系统方法来表征Francisella突变体，这些突变体表现出细胞内生长速率改变或诱导细胞凋亡。RO1的最后一个项目将使用遗传，生化和计算方法的组合来阐明假假芽孢杆菌宿主在疾病的败血症和细胞内阶段的病原体反应。

项目成果

Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model.

• DOI: 10.1371/journal.pntd.0003295
• 发表时间: 2014
• 期刊: PLoS neglected tropical diseases
• 影响因子: 3.8
• 作者: Engelmann F;Josset L;Girke T;Park B;Barron A;Dewane J;Hammarlund E;Lewis A;Axthelm MK;Slifka MK;Messaoudi I
• 通讯作者: Messaoudi I

IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection.

• DOI: 10.1371/journal.ppat.1003039
• 发表时间: 2012
• 期刊: PLoS pathogens
• 影响因子: 6.7
• 作者: Ramos HJ;Lanteri MC;Blahnik G;Negash A;Suthar MS;Brassil MM;Sodhi K;Treuting PM;Busch MP;Norris PJ;Gale M Jr
• 通讯作者: Gale M Jr

A reversed-phase capillary ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) method for comprehensive top-down/bottom-up lipid profiling.

• DOI: 10.1007/s00216-012-5773-5
• 发表时间: 2012-03
• 期刊: ANALYTICAL AND BIOANALYTICAL CHEMISTRY
• 影响因子: 4.3
• 作者: Gao, Xiaoli;Zhang, Qibin;Meng, Da;Isaac, Giorgis;Zhao, Rui;Fillmore, Thomas L.;Chu, Rosey K.;Zhou, Jianying;Tang, Keqi;Hu, Zeping;Moore, Ronald J.;Smith, Richard D.;Katze, Michael G.;Metz, Thomas O.
• 通讯作者: Metz, Thomas O.

A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes.

• DOI: 10.1371/journal.ppat.1003168
• 发表时间: 2013-02
• 期刊: PLoS pathogens
• 影响因子: 6.7
• 作者: Suthar MS;Brassil MM;Blahnik G;McMillan A;Ramos HJ;Proll SC;Belisle SE;Katze MG;Gale M Jr
• 通讯作者: Gale M Jr

Autophagic Killing Effects against Mycobacterium tuberculosis by Alveolar Macrophages from Young and Aged Rhesus Macaques.

• DOI: 10.1371/journal.pone.0066985
• 发表时间: 2013
• 期刊: PloS one
• 影响因子: 3.7
• 作者: Pacheco SA;Powers KM;Engelmann F;Messaoudi I;Purdy GE
• 通讯作者: Purdy GE